· Earnings watch · CORT
Corcept Therapeutics Incorporated (CORT) enters earnings with an 85.5% 12-week gain
The July 29 biotechnology report will test an active weekly trend against weaker Relative Strength.
Corcept Therapeutics Incorporated (CORT) ended the latest week at $95.36 before its July 29 earnings date, with the fiscal period ending June 30. The stock rose 5.3% over one week and 9.2% over four weeks, extending a much larger three-month advance.
Weekly context over 52 weeks shows a strong price path, supported by an active trend and Market Dynamics confirmation at 1.59. The setup is not one-sided: Relative Strength is 36.7, and latest volume was only 1.07 times the 13-week average.